Pre. Settlement | N/A |
Settlement Date | 2023-02-23 |
Open | 185.00 |
Bid | 150.00 |
Last Price | 185.00 |
Day's Range | 185.00 - 185.00 |
Volume | |
Ask | 210.00 |
Congratulations to Michael Elliott, Vice President of Development and Medical Affairs at Gilead, for being named to this year's Empower Advocate Executive Role Model List. The list honors people wh...
FOSTER CITY, Calif., June 02, 2022--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Stacey Ma, PhD will join the company as Executive Vice President, Pharmaceutical Development and Manufacturing, and will become a member of the company’s senior leadership team, reporting to Chairman and Chief Executive Officer Daniel O’Day. Dr. Ma will assume responsibility for Gilead’s Pharmaceutical Development and Manufacturing organization effective July 18, 2022. Dr. Ma will succeed Dr. Yang, who
As a young girl, Betty Chiang was curious to explore how science affected our wellbeing and health. Growing up, she witnessed some family and friends experiencing health issues that were not as pre...